Approval and Monitoring of Narcotic Treatment Programs: A Guide on the Roles of Federal and State Agencies
|
James Cooper, M.D.
Chief, Medical Affairs Branch
Division of Clinical Research
National Institute on Drug Abuse
5600 Fishers Lane, Room 10A-12
Rockville, MD 20857
G. Thomas Gitchel*
Chief, Liaison and Policy Section
Office of Diversion Control
Drug Enforcement Administration
U.S. Department of Justice
Washington, DC 20537
Betty Jones**
Chief, Regulatory Management Branch
Division of Scientific Investigations
Food and Drug Administration
7520 Standish Place
Rockville, MD 20855
Robert Lubran, M.S., M.P.A.
Acting Chief
Quality Assurance and Evaluation Branch
Division of State Programs
Center for Substance Abuse Treatment
5600 Fishers Lane
Rockwall II, 10th Floor
Rockville, MD 20857
Richard Suchinsky, M.D.
Associate Director for Addictive Disorders and Psychiatric Rehabilitation
Mental Health and Behavioral Sciences Service
U.S. Department of Veterans Affairs
810 Vermont Avenue, NW
Washington, DC 20420
| << Back | Table of Content | Next >> |